TopFunds

Eli Lilly And Co

NYSE: LLY

Stock price

1152.22 USD

(+400.75%) 5 years

medicineDrug Manufacturers - General

Insider Transactions

5Y price score: 552
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +400.75%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
17-aug.-26Award41,183.24,9583,004Sulzberger Gabrielledirectorlink
17-aug.-26Award131,183.215,91716,918LUCIANO JUAN Rdirectorlink
17-aug.-26Award81,183.29,91775,418Fyrwald J Erikdirectorlink
17-aug.-26Award101,183.212,41755,745Alvarez Ralphdirectorlink
17-aug.-26Sale(6,500)1,175.1(7,638,150)54,147Jonsson Patrikofficer: EVP & President, LLY Int'llink
10-aug.-26Sale(2,000)1,185.0(2,370,020)1,526Zakrowski Donald Aofficer: SVP, Finance, & CAOlink
07-aug.-26Sale(5,000)1,190.0(5,950,000)11,875Hakim Anatofficer: EVP, GC & Secretarylink
20-jul.-26Award41,146.94,9583,000Sulzberger Gabrielledirectorlink
20-jul.-26Award141,146.915,91716,905LUCIANO JUAN Rdirectorlink
20-jul.-26Award91,146.99,91775,410Fyrwald J Erikdirectorlink

712.0

52-week range

1292.6

1,152.22

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

1.9 %

Dividend Yield TTM

0.6 %

Market cap $

$ 1,085,093

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

38.7

Price / Book TTM

30.4

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

0.4

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

51.8 %

410.8 %

1,406.6 %

Free cash flow per share growth

508.7 %

113.8 %

725.1 %

Earnings per share growth

26.2 %

254.7 %

952.8 %

Dividends

Previous dividend:1.73 per share, Paid, Ex-div date Aug 14, 2026

Analyst ratings

Price Target Low

940

Price Target High

1,500

Price Target Median

1,376

Buy

33

Hold

9

Sell

3

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
2.2
2.5
(0.2)
3.1
8.7
6.5
5.9
6.6
5.8
11.7
23
26.5%
16.2
18.6
21.4
24.6
28.3
29.7
02FCF per share
1.2
3.4
3.3
2.4
3.6
4.7
5.6
4.8
(3.5)
0.5
10
23.5%
8.5
9.3
10.1
11
11.8
9.4
03Dividends per share
Help
Adjusted for splitsLearn more
2
2
2.1
2.3
2.6
3
3.4
3.9
4.5
5.2
6
11.6%
-
-
-
-
-
-
04Dividends payout, %
88.3%
78.9%
(1,074)%
71.5%
29%
43.4%
55.3%
56.6%
77.7%
44.2%
26.1%
(11.5)%
-
-
-
-
-
-
05Revenue
$ 19,959
$ 21,222
$ 19,974
$ 21,493
$ 22,320
$ 24,540
$ 28,318
$ 28,541
$ 34,124
$ 45,043
$ 65,179
12.6%
$ 73,368
$ 82,585
$ 92,961
$ 104,640
$ 117,787
$ 121,320
06ㅤ% Change
-
6.3%
(5.9)%
7.6%
3.8%
10%
15.4%
0.8%
19.6%
32%
44.7%
12.6%
12.6%
12.6%
12.6%
12.6%
12.6%
12.6%
07Net Income
2,408
2,738
(204.1)
3,232
8,318
6,194
5,582
6,245
5,240
10,590
20,640
24%
14,248
16,038
18,053
20,321
22,874
23,560
08ㅤ% Margin
12.1%
12.9%
(1)%
15%
37.3%
25.2%
19.7%
21.9%
15.4%
23.5%
31.7%
19.4% A
19.4%
19.4%
19.4%
19.4%
19.4%
19.4%
09CFO
2,965
4,851
5,616
5,525
4,837
6,500
7,366
7,586
4,240
8,818
16,813
19%
16,679
18,775
21,134
23,789
26,777
27,581
10ㅤ% Of revenue
14.9%
22.9%
28.1%
25.7%
21.7%
26.5%
26%
26.6%
12.4%
19.6%
25.8%
22.7% A
22.7%
22.7%
22.7%
22.7%
22.7%
22.7%
11CAPEX
(1,626)
(1,092)
(2,164)
(3,018)
(1,354)
(2,029)
(1,978)
(2,985)
(7,392)
(8,404)
(7,841)
17%
(9,177)
(10,740)
(12,570)
(14,711)
(17,218)
(20,151)
12ㅤ% Change
-
(32.9)%
98.1%
39.5%
(55.2)%
49.9%
(2.5)%
50.9%
147.6%
13.7%
(6.7)%
17% A
17%
17%
17%
17%
17%
17%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
1,338
3,759
3,452
2,506
3,483
4,471
5,388
4,600
(3,152)
414.3
8,972
21%
7,503
8,035
8,564
9,077
9,560
7,430
14Total assets
35,569
38,806
44,981
43,908
39,286
46,633
48,806
49,490
64,006
78,715
112,476
12.2%
126,200
141,598
158,875
178,261
200,011
224,416
15ㅤ% Change
-
9.1%
15.9%
(2.4)%
(10.5)%
18.7%
4.7%
1.4%
29.3%
23%
42.9%
12.2%
12.2%
12.2%
12.2%
12.2%
12.2%
12.2%
16Total liabilities
20,979
24,725
33,313
32,999
36,587
40,808
39,651
38,714
53,143
64,443
85,941
15.1%
96,427
108,193
121,394
136,206
152,825
171,472
17ㅤ% Of assets
59%
63.7%
74.1%
75.2%
93.1%
87.5%
81.2%
78.2%
83%
81.9%
76.4%
76.4% A
76.4%
76.4%
76.4%
76.4%
76.4%
76.4%
18Shareholders Equity
14,590
14,081
11,668
10,909
2,699
5,825
9,155
10,775
10,864
14,272
26,535
6.2%
29,773
33,405
37,481
42,055
47,186
52,944
19Net Debt
4,312
5,723
7,111
2,978
13,466
12,938
13,066
14,172
22,407
30,376
35,340
23.4%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
1,105,267
1,100,875
1,052,023
1,033,667
957,526
956,590
953,653
950,182
903,284
904,059
898,002
(2.1)%
879,546
861,468
843,763
826,421
809,436
792,800
21ㅤ% Change
-
(0.4)%
(4.4)%
(1.7)%
(7.4)%
(0.1)%
(0.3)%
(0.4)%
(4.9)%
0.1%
(0.7)%
(2.1)%
(2.1)%
(2.1)%
(2.1)%
(2.1)%
(2.1)%
(2.1)%
22ROA
6.8%
7.1%
(0.5)%
7.4%
21.2%
13.3%
11.4%
12.6%
8.2%
13.5%
18.4%
-
11.3%
11.3%
11.4%
11.4%
11.4%
10.5%
23ROE
16.5%
19.4%
(1.8)%
29.6%
308.2%
106.3%
61%
58%
48.2%
74.2%
77.8%
-
47.9%
48%
48.2%
48.3%
48.5%
44.5%
24Interest coverage
22.3
20.9
18.9
24.8
15
20.1
23.3
26.1
22.2
21.8
37.3
-
-
-
-
-
-
-
25Dividend Yield
2.3%
2.7%
2.5%
1.9%
1.9%
1.7%
1.2%
1%
0.8%
0.7%
0.6%
-
-
-
-
-
-
-
26P/E Ratio
38.7
29.5
(444.5)
36.9
15.1
26.1
47.2
55.7
100
65.6
46.6
-
-
-
-
-
-
-
27Stock price range
68-90
66-84
75-88
74-119
107-132
119-173
164-279
235-375
311-619
592-960
626-1110
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
93,130
80,969
88,854
118,928
125,848
161,511
263,418
347,615
524,266
695,267
965,065
26.3%
62,597
72,391
83,164
95,014
108,050
-
29FCF Yield
1.4%
4.6%
3.9%
2.1%
2.8%
2.8%
2.1%
1.3%
(0.6)%
0.1%
0.9%
(4.3)%
12%
11.1%
10.3%
9.6%
8.9%
-
30Average stock price
79.2
75
81.2
96.4
119.6
145.8
221.7
304.7
464.9
776.1
867.8
27.1%
71.2
84
98.6
115
133.5
-
31 CEO
DR
Mr. David A. Ricks